HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
PANDA Study – Mobile App
We are recruiting!
We are currently recruiting with approval under IRB# 19-016641. Please go to our clinical trials webpage for more details about the study: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability — PANDA Mobile App Data Collection
Your baby can help us learn how infants move. We want to understand how all infants move whether or not they have had any medical challenges. In the U.S., one in 10 infants are born at risk for neurodevelopmental disabilities. Early treatment in the first year of life improves long-term outcomes; however, today’s clinical tests are less than adequate. They are difficult to administer, require specialized training, and have limited long-term predictive value. An objective, accurate, easy-to-use tool for early prediction of long-term physical disability is critically needed.
The goal of the PANDA Study – Mobile App is to develop an automated assessment for early and accurate detection of infants at risk for neurodevelopmental disabilities by capitalizing on state-of-the-art sensing and machine learning technologies. By understanding how infants move, this project will help us develop universal noninvasive test for early detection of neurodevelopmental disabilities. This test will scale to infants worldwide, producing an affordable tool for infant health assessment.
Learn more about how the study will be used to develop treatments for infants at-risk for developmental delay. For more details, contact ruwaihn [at] email.chop.edu (ruwaihn[at]email[dot]chop[dot]edu).
If you'd like information about eligibility, technical information about the video, and compensation for study participation, please download the PANDA Mobile App to your Andriod or iOS/ Apple mobile phone.
Leaders
Laura Prosser, PT, PhD
Division of Rehabilitation Medicine
Michelle J. Johnson, PhD
Perelman School of Medicine and School of Engineering, University of Pennsylvania
Konrad Kording
University of Pennsylvania